These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

77 related items for PubMed ID: 1794134

  • 1. Comparison of urinary transforming growth factor-alpha in women with disseminated breast cancer and healthy control women.
    Stromberg K, Duffy M, Fritsch C, Hudgins WR, Sharp ES, Murphy LD, Lippman ME, Bates SE.
    Cancer Detect Prev; 1991; 15(4):277-83. PubMed ID: 1794134
    [Abstract] [Full Text] [Related]

  • 2. Urinary transforming growth factors in neoplasia: separation of 125I-labeled transforming growth factor-alpha from epidermal growth factor in human urine.
    Stromberg K, Hudgins WR.
    Cancer Res; 1986 Nov; 46(11):6004-10. PubMed ID: 3019543
    [Abstract] [Full Text] [Related]

  • 3. Immunoreactive alpha transforming growth factor activity in effusions from cancer patients as a marker of tumor burden and patient prognosis.
    Arteaga CL, Hanauske AR, Clark GM, Osborne CK, Hazarika P, Pardue RL, Tio F, Von Hoff DD.
    Cancer Res; 1988 Sep 01; 48(17):5023-8. PubMed ID: 3165707
    [Abstract] [Full Text] [Related]

  • 4. Elevation of transforming growth factor alpha and its relationship to the epidermal growth factor and alpha-fetoprotein levels in patients with hepatocellular carcinoma.
    Yeh YC, Tsai JF, Chuang LY, Yeh HW, Tsai JH, Florine DL, Tam JP.
    Cancer Res; 1987 Feb 01; 47(3):896-901. PubMed ID: 2433030
    [Abstract] [Full Text] [Related]

  • 5. Distinct high-performance liquid chromatography pattern of transforming growth factor activity in urine of cancer patients as compared with that of normal individuals.
    Kimball ES, Bohn WH, Cockley KD, Warren TC, Sherwin SA.
    Cancer Res; 1984 Aug 01; 44(8):3613-9. PubMed ID: 6331653
    [Abstract] [Full Text] [Related]

  • 6. Transforming growth factor beta: potential autocrine growth inhibitor of estrogen receptor-negative human breast cancer cells.
    Arteaga CL, Tandon AK, Von Hoff DD, Osborne CK.
    Cancer Res; 1988 Jul 15; 48(14):3898-904. PubMed ID: 3164252
    [Abstract] [Full Text] [Related]

  • 7. Epidermal growth factor receptors in human breast carcinoma cells: a potential selective target for transforming growth factor alpha-Pseudomonas exotoxin 40 fusion protein.
    Arteaga CL, Hurd SD, Dugger TC, Winnier AR, Robertson JB.
    Cancer Res; 1994 Sep 01; 54(17):4703-9. PubMed ID: 8062268
    [Abstract] [Full Text] [Related]

  • 8. Mitogenic growth factors in breast fluid obtained from healthy women: evaluation of biological and extraneous sources of variability.
    Gann P, Chatterton R, Vogelsong K, Dupuis J, Ellman A.
    Cancer Epidemiol Biomarkers Prev; 1997 Jun 01; 6(6):421-8. PubMed ID: 9184775
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Tumor necrosis factor alpha enhances secretion of transforming growth factor beta2 in MCF-7 breast cancer cells.
    Danforth DN, Sgagias MK.
    Clin Cancer Res; 1996 May 01; 2(5):827-35. PubMed ID: 9816237
    [Abstract] [Full Text] [Related]

  • 11. Transforming growth factor-alpha and insulin-like growth factor-I, but not epidermal growth factor, elicit autocrine stimulation of mitogenesis in endometrial cancer cell lines.
    Reynolds RK, Hu C, Baker VV.
    Gynecol Oncol; 1998 Aug 01; 70(2):202-9. PubMed ID: 9740691
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A soluble transforming growth factor beta type III receptor suppresses tumorigenicity and metastasis of human breast cancer MDA-MB-231 cells.
    Bandyopadhyay A, Zhu Y, Cibull ML, Bao L, Chen C, Sun L.
    Cancer Res; 1999 Oct 01; 59(19):5041-6. PubMed ID: 10519421
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Identification of breast cancer cell line-derived paracrine factors that stimulate osteoclast activity.
    Pederson L, Winding B, Foged NT, Spelsberg TC, Oursler MJ.
    Cancer Res; 1999 Nov 15; 59(22):5849-55. PubMed ID: 10582709
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.